Seeing Is Believing
Healthcare - Sector
MYGN is currently covered by 4 analysts with an average price target of $6.14. This is a potential upside of $4.27 (57.84%) from yesterday's end of day stock price of $3.89.
Myriad Genetics's activity chart (see below) currently has 104 price targets and 88 ratings on display. The stock rating distribution of MYGN is 71.43% HOLD and 28.57% BUY.
Analysts average stock forecasts to be materialized ratio is 65.1% with an average time for these price targets to be met of 168.3 days.
Highest price target for MYGN is $9, Lowest price target is $2, average price target is $6.14.
Most recent stock forecast was given by LU LI from UBS on 09-Sep-2026. First documented stock forecast 31-May-2013.
Currently out of the existing stock ratings of MYGN, 5 are a HOLD (71.43%), 2 are a BUY (28.57%).
3/26/09 2 for 1
9/12/00 2 for 1
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Dec-2024
$3.6
$-0.29 (-7.46%)
$6
11 days ago
(09-Sep-2026)
4/6 (66.67%)
$0.41 (12.85%)
66
Buy Since 15-May-2025
$2
$-1.89 (-48.59%)
$8.5
19 days ago
(01-Sep-2026)
0/5 (0%)
$-1.18 (-37.11%)
Hold Since 24-Feb-2026
$5.5
$-0.38 (-6.46%)
$6
4 months 14 days ago
(06-May-2026)
13/14 (92.86%)
$1.39 (33.82%)
124
Hold Since 01-Mar-2023
$9
$3.12 (53.06%)
$8
10 months 16 days ago
(04-Nov-2025)
3/7 (42.86%)
$2.54 (39.32%)
114
Hold Since 19-Sep-2024
$7
$1.12 (19.05%)
$16
1 years 4 months ago
(20-May-2025)
1/3 (33.33%)
$2.55 (57.30%)
114
What is MYGN (Myriad Genetics) average time for price targets to be met?
Which analyst most recently updated their price target on MYGN (Myriad Genetics)?
Which analyst has the most public recommendations on MYGN (Myriad Genetics)?
Which analyst is the currently most bullish on MYGN (Myriad Genetics)?
Which analyst is the currently most reserved on MYGN (Myriad Genetics)?